entertainment -WSS

entertainment

author：Wikipedia 2025-09-06 05:03:17 - browse：33

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： How Vertex's cystic fibrosis drug is changing patients' lives

focus

hotspot

WSS

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Biotech lab space demand falls sharply

Thermo Fisher plant for manufacturing gene therapies to expand

Biotech stock slump in 2023: awaiting the turnaround

Timeline: Special counsel's probe into Trump's handling of classified documents

It's been 20 years since Dolly the sheep. Where's my clone?

hotspot

entertainment

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Interest rates are at a 22

Medical leaders decry Supreme Court decision on affirmative action

CDC's new outbreak response network to include Northeastern

What does generative AI mean for health care? We asked experts

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Medicare proposal to cover medical devices draws a mixed reaction

Lasker Awards 2023: Winners in biomedical research

In age of alternative facts, a scholarly course on calling out crap

What Congress can do to address the rural doctor shortage

knowledge

Behind warning on Apellis’s eye drug lies a conflict of interest

Behind warning on Apellis’s eye drug lies a conflict of interest

Emergency workers more likely to restrain Black patients: study

Trump allegedly attempted to have surveillance video deleted: Special Counsel

CommonSpirit Health keeps growing, even as it loses money

Thermo Fisher plant for manufacturing gene therapies to expand

focus

focus

hotspot

Wikipedia